Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.
Tavan JanvilisriKawin LeelawatSittiruk RoytrakulAtchara PaemaneeRutaiwan TohtongPublished in: Disease markers (2015)
Novel serum biomarkers to distinguish CCA from BBTDs were identified using a proteomic approach. Further validation of these proteins has the potential to provide a biomarker for differentiating CCA from BBTDs.